Top Markets
#1 Akedo Akedo +57.65%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.04%
#4 Velvet Velvet +42.35%
#5 Black Phoenix Black Phoenix +34.54%
#6 τemplar τemplar +23.53%
#7 Cross Cross +20.01%
#8 Ribbita by Virtuals Ribbita by Virtuals +16.20%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.38%
#10 Perle Perle +15.05%
Coin of the day
Akedo Akedo
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Evofem Biosciences, Inc. Evofem Biosciences, Inc.

Evofem Biosciences, Inc.

EVFM
Classificação em ações #38408
Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated... Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated to innovating and bringing to market treatments that address critical underserved areas in women's sexual and reproductive health. Their leading commercial offering is Phexxi, a vaginal gel specifically designed as a contraceptive. Additionally, the company is actively advancing EVO100, an antimicrobial vaginal gel under development, intended to prevent the urogenital spread of both Chlamydia trachomatis and Neisseria gonorrhoeae infections in women. The company's main office is situated in San Diego, California.
Preço da ação
$0.007524
Valor de mercado
$997.16K
Variação (1 dia)
-5.95%
Variação (1 ano)
-22.43%
País
US
Negociar Evofem Biosciences, Inc. (EVFM)

Categoria

Healthcare
Histórico de preços das ações de Evofem Biosciences, Inc. (EVFM)
Preço de fecho mais alto: $0.01 em 2026-08-01

Preço de fecho mais baixo: $125.17K em 2014-11-01
Histórico de preços das ações da Evofem Biosciences, Inc. de 2014 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -6.91%
2025 7.85%
2024 -86.14%
2023 -99.23%
2022 -98.83%
2021 -81.81%
2020 -64.76%
2019 68.56%
2018 -60.71%
2017 48.90%
2016 -76.12%
2015 -40.99%
2014 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 29.45%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.68%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 7.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.25%
BE